Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners
Title | Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners PDF eBook |
Author | Marianne Davies |
Publisher | Springer |
Pages | 120 |
Release | 2019-07-16 |
Genre | Medical |
ISBN | 3030165507 |
This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe and effective lung cancer treatment. In this era of personalized medicine, nurses and APP’s are responsible for guiding patients from diagnosis through treatment. This starts with the identification of patients that can benefit from these therapies, the key role of biopsy acquisition (ie. what to test, when and how often) and treatment selection based on the mutation identified. Readers will learn about the mechanisms of action, administration, potential adverse side effects and unique management strategies for these targeted agents. Lung cancer continues to be the leading cause of cancer death in the United States and worldwide. Recent advances in the identification of specific oncogenic mutations that drive cancer development, growth and metastasis have led to major paradigm shifts in lung cancer treatment. Sophisticated methods are required to identify specific mutations at the time of diagnosis. This book explains how molecularly targeted therapies have been developed that target these drivers. To date, several tyrosine kinase inhibitors have been approved to target the epidermal growth factor receptor (EGFR), EML4-ALK ,ROS1 and BRAF. Most recently, immune checkpoint inhibitors have been approved with some indication that efficacy may be enhanced for patients who overexpress PD-L1. While some driver mutations have been identified, there is ongoing investigation into additional mutations. In the case of driver mutations, lung cancers will develop resistance to therapy. This book provides nurses and APP’s with the mechanisms of resistance that have been identified such as T790 mutation and many others in the EGFR mutation, and shows how the next level of drug development is focused on identifying mechanisms of resistance and development of new agents that overcome these mutations. With this book in hand, nurses and practitioners will be able to navigate patients through this ever expanding field of lung cancer treatment.
Molecular Targeted Therapy of Lung Cancer
Title | Molecular Targeted Therapy of Lung Cancer PDF eBook |
Author | Yuichi Takiguchi |
Publisher | Springer |
Pages | 321 |
Release | 2017-01-24 |
Genre | Medical |
ISBN | 9811020027 |
This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety. Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.
Guide to Targeted Therapies: Treatment Resistance in Lung Cancer
Title | Guide to Targeted Therapies: Treatment Resistance in Lung Cancer PDF eBook |
Author | Federico Cappuzzo |
Publisher | |
Pages | |
Release | 2015 |
Genre | |
ISBN | 9783319207421 |
This text is a concise and up-to-date review, which discusses the background, development and mechanisms of resistance, testing methods and technology, current and emerging therapies and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of treatment resistance in lung cancer as well as a summary of current therapies will benefit from this succinct guide.
Lung Cancer
Title | Lung Cancer PDF eBook |
Author | Alba Fabiola Costa Torres |
Publisher | BoD – Books on Demand |
Pages | 206 |
Release | 2018-10-31 |
Genre | Medical |
ISBN | 1789843499 |
Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer.
Targeted Therapies in Non-small Cell Lung Cancer
Title | Targeted Therapies in Non-small Cell Lung Cancer PDF eBook |
Author | |
Publisher | |
Pages | 40 |
Release | 2005 |
Genre | Lungs |
ISBN |
Targeted Therapies in Non-small Cell Lung Cancer
Title | Targeted Therapies in Non-small Cell Lung Cancer PDF eBook |
Author | Nancy G. Houlihan |
Publisher | |
Pages | 40 |
Release | 2007 |
Genre | Lungs |
ISBN |
Educational objectives: After completing this independent study, the participant will be able to: Discuss the rationale for targeting the human epidermal growth factor family of receptors in cancer; Describe the role of HER1/EGFR in malignancy; Summarize the clinical data regarding the role of HER1/EGFR inhibitors; Identify key elements related to symptom management and patient education related to HER1/EGFR therapies in non-small cell lung cancer. - p. 1.
Holland-Frei Cancer Medicine
Title | Holland-Frei Cancer Medicine PDF eBook |
Author | Robert C. Bast, Jr. |
Publisher | John Wiley & Sons |
Pages | 2004 |
Release | 2017-03-10 |
Genre | Medical |
ISBN | 111900084X |
Holland-Frei Cancer Medicine, Ninth Edition, offers a balanced view of the most current knowledge of cancer science and clinical oncology practice. This all-new edition is the consummate reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. A translational perspective throughout, integrating cancer biology with cancer management providing an in depth understanding of the disease An emphasis on multidisciplinary, research-driven patient care to improve outcomes and optimal use of all appropriate therapies Cutting-edge coverage of personalized cancer care, including molecular diagnostics and therapeutics Concise, readable, clinically relevant text with algorithms, guidelines and insight into the use of both conventional and novel drugs Includes free access to the Wiley Digital Edition providing search across the book, the full reference list with web links, illustrations and photographs, and post-publication updates